ORIGINAL RESEARCH article
Front. Surg.
Sec. Thoracic Surgery
Volume 12 - 2025 | doi: 10.3389/fsurg.2025.1602167
This article is part of the Research TopicManaging COVID-19 in Heart and Lung Transplant Patients: Challenges and SolutionsView all 6 articles
Long COVID risk factors and outcomes among solid organ transplant recipients: a retrospective cohort study
Provisionally accepted
- 1University of Texas Health Science Center at Houston, Houston, United States
- 2Department of Surgery, Houston Methodist Hospital, Houston, Texas, United States
- 3Department of Medicine, Houston Methodist Hospital, Houston, Texas, United States
- 4Department of Pathology and Genomic Medicine, Houston Methodist Research Institute, Houston, Texas, United States
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background: Solid organ transplant (SOT) recipients are not only at increased risk of morbidity and mortality due to acute COVID-19 but may also experience poor long-term outcomes due to post-acute COVID-19 syndromes, including long COVID. Methods: This retrospective, registrybased chart review evaluated graft failure and mortality among SOT recipients diagnosed with COVID-19 at a large, urban transplant center in Houston, Texas, USA. Patient populations were analyzed separately according to their long COVID status at the time of transplant to preserve the temporal relationship between the exposure (long COVID) and the outcome (graft failure or mortality). Results: In total, 146 (5%, 146/3,202) patients were diagnosed with long COVID, 443 (14%, 443/3,202) patients expired during the study period, and 202 (6%, 202/3,202) were diagnosed with graft failure. Overall, patients with long COVID were older, had an increased comorbidity burden, and were more likely to be lung, heart, or heart-lung recipients compared to those who were not diagnosed with long COVID. Long COVID was not significantly associated with death or graft failure in this study population, though relationships varied across subpopulations. Conclusions: The observed differences between patients diagnosed with COVID-19 and long COVID before and after transplant warrant additional studies as the proportion of people with some SARS-CoV-2 infection history approaches 90%. Future investigations may prioritize longitudinal follow-up of long COVID patients diagnosed before or after transplant to determine specific etiologies of long-term morbidity and mortality.
Keywords: COVID - 19, Long Covid, Solid organ transplant (SOT), Epidemiology, Infectious diseases
Received: 28 Mar 2025; Accepted: 04 Aug 2025.
Copyright: © 2025 Sandoval, Moore, Huang and Graviss. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Micaela Sandoval, University of Texas Health Science Center at Houston, Houston, United States
Edward A Graviss, University of Texas Health Science Center at Houston, Houston, United States
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.